European Companies Search Engine

Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

12 EU fundings (€0.00): Immune Safety Avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies … BdlYear 2019 EU Research and Innovation programme "Horizon"

Text

Sanofi-Aventis Recherche et Developpement SA, Gentilly, France

01/03/2019 EU funding (€1,199,125): Efficiently Networking European Neurodegeneration Research
01/12/2019 EU funding (€11M): Immune Safety Avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies
01/11/2019 EU funding (€12M): EU Patient- cEntric clinicAl tRial pLatform
01/02/2019 EU funding (€14M): Translational Safety Biomarker Pipeline (TransBioLine): Enabling development and implementation of novel safety biomarkers in clinical trials and diagnosis of disease
01/04/2019 EU funding (€15.3M): Building an ecosystem for better monitoring and communicating of medication safety in pregnancy and breastfeeding: validated and regulatory endorsed workflows for fast, optimised evidence generation
01/03/2019 EU funding (€17.8M): Integrated IMMUnoprofiling of large adaptive CANcer patients cohorts
14/08/2019 EU funding (€19M): Trials@Home: Center of Excellence – Remote Decentralised Clinical Trials
01/11/2019 EU funding (€21M): Identifying Digital Endpoints to Assess FAtigue, Sleep and acTivities in daily living in Neurodegenerative disorders and Immune-mediated inflammatory diseases
01/04/2019 EU funding (€25.4M): Connecting digital mobility assessment to clinical outcomes for regulatory and clinical endorsement
01/03/2019 EU funding (€5,331,000): Neurotoxicity De-Risking in Preclinical Drug Discovery
01/03/2019 EU funding (€6,700,000): CARdiomyopathy in type 2 DIAbetes mellitus
01/01/2019 EU funding (€9,000,000): Investigating Mechanisms and Models Predictive of Accessibility of Therapeutics (IM2PACT) Into The Brain
CSV export

Investigative Journalism

Uncover International Corporate Connections with our Free Investigative-Account

This filing was translated from German to English. The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Sanofi-Aventis Recherche et Developpement SA, Gentilly, France.

Creative Commons License The visualizations for "Sanofi-Aventis Recherche et Developpement SA - 12 EU fundings (€0.00): Immune Safety Avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies …" are provided by North Data and may be reused under the terms of the Creative Commons CC-BY license.

Printing is only available to North Data premium service subscribers.